Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Cancer Clinical Trials
Contact Name Hematology and Oncology Clinical Trials
Contact Phone (312) 942-8312
Contact E-mail clinical_trials@rush.edu

For information about most clinical trials in cancer, please see our special cancer clinical trials database. Other open trials may be listed below. If you have questions about clinical trials in cancer, call Laurie Smith, director of research, Division of Hematology/Oncology, at (312) 942-8312.

 

Included in this section:

Brachytherapy for Early Stage Breast Cancer: Clinical study to evaluate the safety and performance of the Axxent electronic brachytherapy system in women with resected, early stage breast cancer

Educational Approaches to Weight Management in Breast Cancer Survivors: Information on clinical trials at Rush University Medical Center in Chicago that measure the effectiveness of educational approaches to weight management in breast cancer survivors

Favorable-Risk Prostate Cancer Study: RTOG 0415: A phase III randomized study of hypofractionated 3D-CRT/IMRT versus conventionally fractionated 3D-CRT/IMRT in patients with favorable-risk prostate cancer

Hematology and Oncology Clinical Trials: Database of cancer clinical trials at Rush University Medical Center in Chicago.

Intermediate Risk Prostatic Cancer Study: RTOG 0232: A phase III study comparing combined external beam radiation and transperineal interstitial prmanent brachytherapy with brachytherapy alone for selected patients with intermediate risk prostatic cancer

Locally Advanced Rectal Cancer: Randomized phase II trial of neoadjuvant combined modality therapy for locally advanced rectal cancer

Prostate Cancer Study: Phase 3, double blind trial, using investigational product in asymptomatic subjects with Gleason sum equal to or lesser than 7, metastatic androgen independent prostatic adenocarcinoma

Prostate Carcinoma Study: Helical tomotherapy treatment of dominant intraprostatic lesions in patients with prostate carcinoma utilizing magnetic resonance imaging and spectroscopic guidance



Promotional Information

Clinical Trials Home
Cancer Clinical Trials
Brachytherapy for Early Stage Breast Cancer
Favorable-Risk Prostate Cancer Study
Hematology/Oncology Trials
Intermediate Risk Prostatic Cancer Study
Prostate Cancer Study
Prostate Carcinoma Study
Rectal Cancer Study
Weight Management in Breast Cancer Survivors

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois